🚨 Regarding MERL, I must issue a clearer risk warning.

As someone who has been tracking this asset's unlock structure, I believe the concentrated unlock cycle in December warrants close attention. This month, there are four key dates: 12/12, 12/15, 12/16, and 12/19, with approximately 70 million OTC tokens entering circulation.

Based on my current observations:

1️⃣ The risk from market sentiment is significantly higher than the actual selling pressure.
Regardless of the actual sell volume, the concentrated unlock itself causes the market to enter "risk-avoidance mode" early, with active buying shrinking and short-term volatility amplifying.

2️⃣ Early OTC costs are relatively low, and short-term arbitrage motivation objectively exists.
This means that every rebound in price could trigger profit-taking by some holders, making resistance above more sensitive.

3️⃣ Continuous unlocking combined with weak liquidity creates a cumulative risk effect.
Markets are most prone to misaligned expectations and sharp short-term fluctuations during this phase.
⚠ Based on these factors, my personal stance is very clear: December is a window for increased risk. It is advisable to strictly control positions, avoid emotional leverage, and be psychologically prepared for short-term volatility.

— Caution is always wise, especially during dense unlock periods.